It is possible that IL-17 is just part of tumor promoting inflammation factors or that blockade of IL-17 diminishes the promoting effects of inflammation but can not restore the activity of tumor specific T cells to eliminate tumors. This evidence concerns the gene IL17A and neoplasm.